Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
Clinical trial NCT07142252 · RECRUITING
Trial details
- NCT number
- NCT07142252
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-14
- Primary completion
- 2028-05-25
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.